Dr. Souvik Modi received his PhD from the National Centre for Biological Sciences, Tata Institute for Fundamental Research (TIFR) in India, where he developed and patented the use of DNA-based nanoprobes as novel sensors for lysosomal ion balance. Dr. Modi carried out postdoctoral studies at the University College London, developing a nanobody-mediated probe for tracking neurotransmitter receptors in brain slices. He then completed a second postdoctoral fellowship at TIFR, where he studied the effect of actin and mitochondria interactions on touch responses in nematode worms. Dr. Modi currently heads research and development at Esya Labs, where he is developing early diagnostic platforms for neurodegenerative disorders. He manages a team of scientists investigating lysosomal dysfunction, transcriptomics and genetics to establish biomarker panels for Alzheimer’s and Parkinson’s Diseases. Dr. Modi continues to develop novel and innovative sensors to probe the role of enzymes in endo-lysosomal pathways in disease.
Associated Grants
-
Esya PD360: A Multi-parametric Platform for Establishing a Novel Lysosome-based Biomarker and Identifying Therapeutic Interventions for Parkinson’s Disease
2022